The law, signed Wednesday, allows a manufacturer of an experimental treatment to provide it to a patient who has a recommendation from a treating physician and has been unable to participate in a clinical trial.
Teresa Bonner | tbonner@pennlive.com, The Patriot-News
Wed, 10/11/2017 - 12:11pm
The law, signed Wednesday, allows a manufacturer of an experimental treatment to provide it to a patient who has a recommendation from a treating physician and has been unable to participate in a clinical trial.